Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Formycon AG

Market Cap 346M 396M 320M 299M 561M 37.46B 566M 3.81B 1.48B 18.42B 1.49B 1.46B 63.99B P/E 2026 *
-32.2x
P/E 2027 * 11.1x
Enterprise Value 415M 475M 384M 359M 673M 44.93B 678M 4.57B 1.78B 22.09B 1.78B 1.75B 76.74B EV / Sales 2026 *
5.71x
EV / Sales 2027 * 3.8x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day-0.71%
1 week-2.00%
Current month-13.27%
1 month-2.24%
3 months+14.89%
6 months-19.67%
Current year-23.44%
1 week 19.34
Extreme 19.34
20.4
1 month 19.34
Extreme 19.34
22.7
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
31.3
3 years 15.8
Extreme 15.8
69.6
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap.
25-02-20Buy

Chief Technology Officer

160 0.0009%
24-04-28Buy

Executive/Senior Manager

1,200 0.0068%
24-04-23Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%-2.00%-25.62%-69.13% 400M
+0.34%+1.09%-10.67%-5.05% 43.13B
+1.73%+3.59%+318.08%+564.04% 34.65B
+0.61%+1.34%+10.00%+46.20% 30.03B
+0.02%-5.93%+8.45%-21.44% 28B
-1.06%-2.60%+9.08%+21.51% 24.45B
-1.23%+2.11% - - 14.34B
-0.99%-2.53%+47.29%+102.88% 13.14B
+1.54%+0.16%+6.69%+8.89% 12.53B
+2.39%+2.61%+102.86%+84.20% 12.25B
Average +0.26%-0.38%+51.80%+81.34% 21.29B
Weighted average by Cap. +0.40%-0.10%+66.85%+116.35%

Financials

2026 *2027 *
Net sales 72.73M 83.24M 67.28M 62.8M 118M 7.87B 119M 799M 311M 3.87B 313M 306M 13.44B 121M 139M 112M 105M 197M 13.12B 198M 1.33B 519M 6.45B 521M 510M 22.42B
Net income -10.92M -12.5M -10.1M -9.43M -17.7M -1.18B -17.83M -120M -46.71M -581M -46.93M -45.91M -2.02B 30.87M 35.33M 28.55M 26.65M 50.03M 3.34B 50.4M 339M 132M 1.64B 133M 130M 5.7B
Net Debt 69.04M 79.01M 63.86M 59.61M 112M 7.47B 113M 759M 295M 3.67B 297M 290M 12.75B 115M 131M 106M 99.2M 186M 12.43B 188M 1.26B 491M 6.11B 494M 483M 21.22B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
203
Date Price Change Volume
26-06-22 19.60 -0.71% 5,017
26-06-19 19.74 +0.71% 2,858
26-06-18 19.60 -1.71% 8,050
26-06-17 19.94 -0.20% 5,121
26-06-16 19.98 -0.10% 18,879
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.60EUR
Average target price
39.67EUR
Spread / Average Target
+102.38%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!